A system to determine short-term prognosis in patients with cirrhosis and hepatorenal syndrome
A technology for syndrome and liver cirrhosis, applied in the field of medicine, can solve problems such as the lack of short-term prognosis judgment methods for patients with liver cirrhosis and hepatorenal syndrome, and achieve the effect of prolonging survival time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027]A retrospective collection of 362 patients with liver cirrhosis and hepatorenal syndrome diagnosed for the first time from January 2013 to December 2014, 62 cases of primary kidney disease were excluded, 52 cases of incomplete clinical data, and finally 246 patients were eligible for inclusion standard. 196 patients with hepatorenal syndrome were used for modeling, of which 130 survived and 66 died; 50 patients with hepatorenal syndrome were used for verification, of which 12 survived and 38 died. Inclusion criteria for hepatorenal syndrome: HRS was diagnosed and typed according to the definition and diagnostic criteria of HRS published by the International Ascites Research Group in 2007. 1) Liver cirrhosis with ascites; 2) Serum creatinine > 133 μmol / L; 3) Diuretics stopped for at least 2 days and the serum creatinine value did not improve after volume expansion with albumin (recommended albumin infusion dose 1g / kg, up to 100g / d, the improvement of serum creatinine sho...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com